Goodacre, Simon Charles,Labadie, Sharada,Liang, Jun,Ortwine, Daniel Fred,Ray, Nicholas Charles,Wang, Xiaojing,Zbieg, Jason,Zhang, Birong
申请号：
AU2015367509
公开号：
AU2015367509A1
申请日:
2015.12.17
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Described herein are tetrahydro-pyrido[3,4-b]indol-1-yl compounds with estrogen receptor modulation activity or function having the Formula (I) structure and stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula (I) compounds, as well as methods of using such estrogen receptor modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
